Our achievements. Our accomplishments. Our impact.



  • Cancer Stem Cells

    A seminal Canadian discovery demonstrated that cancer stem cells are a significant reason for high relapse rates after cancer treatments. In recognition of this, the Stem Cell Network has invested heavily finding ways to target and attack them.

    READ STORY

  • Catalyzing New Organizations

    The Stem Cell Network was critical for strategically identifying structural gaps in the Canadian stem cell research landscape and bringing together diverse stakeholder groups to seize those opportunities through the incubation and launch of new organizations.

    READ STORY

  • Till & McCulloch Meetings

    The Stem Cell Network’s Annual General Meeting, which metamorphosed into the Till & McCulloch Meetings, is a one-of-a-kind venue for trainees and young scientists to network and gain experience in the competitive field of regenerative medicine.

    READ STORY

  • Blood Stem Cell Expansion

    Over more than a decade of targeted funding, the Stem Cell Network harnessed the strength of world-leading Canadian researchers to develop technologies to increase quantities of blood stem cells for expanded therapeutic use and to overcome a significant hurdle in the delivery of cell-based treatments to patients.

    READ STORY

  • Ethical, Legal and Social Issues

    SCN established and funded a world-leading arms-length research program to examine the key social, legal and ethical implications of stem cell research and, based upon this credible and research-based evidence, has provided critical policy recommendations to government that have impacted not only how research is conducted in Canada, but how Canadians will access potential therapies in the future.

    READ STORY

  • Evidence-Based Policy Making

    When the Stem Cell Network launched in 2001, its most pressing goal was to address the policy vacuum that was constraining stem cell research in Canada. SCN and its members provided credible, research-based evidence and recommendations that were critical in the development of Canada’s regulatory landscape for stem cell research.

    READ STORY